ANDA 76269, held by Teva. Metformin Hydrochloride.
As of Nov 16, 2026, ANDA 76269 (Metformin Hydrochloride), held by Teva, was first approved by FDA on Jun 18, 2004, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 18, 2004 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metformin Hydrochloride500MG · tablet, extended release;oral | Metformin Hydrochloride | Rx |
| Aug 11, 2026 | Supplement 23Labeling · Standard review | Approved | None posted |
| Aug 1, 2024 | Supplement 18Labeling · Standard review | Approved | None posted |
| Aug 1, 2024 | Supplement 19Labeling · Standard review | Approved | None posted |
| May 20, 2012 | Supplement 8Labeling | Approved | None posted |
| Oct 22, 2010 | Supplement 13Labeling | Approved | None posted |
| Apr 27, 2010 | Supplement 11Labeling | Approved | None posted |
| Apr 18, 2007 | Supplement 6Labeling | Approved | None posted |
| Jan 3, 2007 | Supplement 5Labeling | Approved | None posted |
| Jun 18, 2004 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters